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A B S T R A C T   
Background: Cognitive problems are a common and debilitating symptom of multiple sclerosis (MS). Screening 
and treatment for cognitive problems are recommended, however these are not routinely delivered in UK clinics. 
We collected and synthesised stakeholder perspectives to develop a care pathway for cognitive problems in MS 
and produce a logic model, illustrating how this pathway might operate. 
Methods: Forty-nine stakeholders, including people with MS and care providers, participated in semi-structured 
interviews and focus groups. Participants viewed information that illustrated how the pathway might work and 
provided feedback. Data, transcribed verbatim and analysed using Framework Analysis, were mapped onto a 
preliminary logic model and accompanying thematic framework. 
Results: The proposed pathway was perceived as helpful in providing standardised support for a neglected MS 
symptom. Training packages, online cognitive screening, and triaging decisions were viewed as crucial activities. 
Shared responsibility, a person-centred approach, and addressing the complexity of cognitive problems were 
important engagement mechanisms. Allocating time during clinic appointments and within staff workloads were 
essential resources for implementation. 
Conclusion: Our co-constructed MS cognitive screening and management pathway will be evaluated for clinical 
and cost-effectiveness in a trial. However, in the interim, clinicians can adapt and implement this pathway in 
their own services and evaluate it locally.   
1. Introduction 
Cognitive problems affect up to 70% of people with MS (pwMS) [1] 
and can negatively impact quality of life and vocational activities [2–4]. 
Consequently, routine screening and management for cognitive prob-
lems in MS has been internationally recommended [6], with addressing 
cognitive problems a ‘top 10′ research priority for pwMS [7]. 
Despite these calls to action, UK MS services do not have an estab-
lished care pathway which integrates these recommendations. A UK- 
wide survey of clinicians found variation in cognitive assessments 
used, often with inappropriate screening tools used rather than the 
recommended tests [8]. We also found a lack of consistency in reporting 
cognitive rehabilitation interventions, particularly regarding the con-
tent of interventions and their underlying framework [9]. These issues 
make it difficult for healthcare services to consistently and systemati-
cally implement cognitive screening and rehabilitation [10]. To address 
this gap, we aimed to develop a multi-agency, co-constructed, clinical 
pathway to forge a consensus on screening and managing cognitive 
problems in MS, and how to go about this. 
Medical Research Council (MRC) guidelines stress the importance of 
theory in developing and evaluating complex interventions [11]. Here we 
propose an initial logic model (Fig. 1) which depicts the theory under-
pinning a screening and management pathway for cognitive problems in 
MS. Our model was informed by literature reviews [12–14], theory (e.g., 
Behaviour Change Wheel [15]), Patient and Public Involvement (PPI), 
clinical experience, and service realities. It adopts a Situation-Inputs- 
Outputs-Mechanism-Outcome configuration [16]. 
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Fig. 1. Initial Logic Model.  
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Situation describes the contextual features that pre-date the intro-
duction of the pathway; including the high prevalence of cognitive 
problems, lack of standardised screening and support for cognitive 
problems (particularly mild-moderate problems [17,18], and healthcare 
recommendations which drive the focus of clinical care (e.g., NICE 
recommends screening and managing cognitive problems, but this is not 
based on robust evidence and does not refer to a particular assessment or 
treatment [19]). Inputs are the resources required to support the 
pathway. Outputs describe the products created by the activities of the 
pathway. Mechanisms are mediating factors and obstacles between the 
introduction of the pathway and the resulting outcomes (e.g., stake-
holders need to be engaged and supported; and the pathway accessible 
and flexible for implementation). Outcomes describe what results from 
the pathway. The specifics of these factors can be found in Fig. 1. 
Logic models are dynamic, they represent working hypotheses and 
are modified iteratively as new insights emerge based on primary (e.g., 
stakeholder consultation, evaluation studies) or secondary data (e.g., 
existing literature/policy) [20]. Conducting primary research with key 
stakeholders can enhance theoretical understanding of the processes of 
change [21]. Exploring the views of key stakeholders at an early stage 
also helps to produce a co-constructed output [22] that empowers and 
engages stakeholders [23]. 
Here, stakeholder perspectives were used to develop a multi-agency 
cognitive screening and management pathway. This study is part of the 
Neuropsychological Evaluation and Rehabilitation in Multiple Sclerosis 
(NEuRoMS) project [24] which will evaluate the efficacy of this pathway 
across six UK MS clinics. 
2. Material and methods 
Ethical approval was granted by the University of Nottingham Fac-
ulty of Medicine and Health Sciences Ethics Committee (reference: 
263–1903). All participants provided informed consent prior to data 
collection. 
2.1. Recruitment 
We sought to interview a broad range of stakeholders with comple-
mentary perspectives on a screening and management pathway for 
cognitive problems, we selected purposively from those willing to be 
interviewed to generate this. 
Eligible participants were 18 years or older, able to communicate in 
English and provide informed consent. Our stakeholders included pwMS 
(diagnosed with MS), family members (relatives or carers for pwMS), MS 
charity volunteers, clinicians (neurologists, MS nurse specialists, neu-
ropsychologists, occupational therapists (OTs) and neuro- 
physiotherapists working clinically with pwMS), and healthcare com-
missioners (working within a Clinical Commissioning Group that com-
mission National Health Service [NHS] services). 
PwMS, family members and charity volunteers were recruited 
through PPI networks, social media, MS charities, and by word of 
mouth. Clinicians and commissioners were recruited through profes-
sional networks. 
Participants were contacted by email or phone and invited to a focus 
group or an interview (in-person, or via telephone/video conferencing), 
based on their preference. 
2.2. Data collection 
Semi-structured interviews were conducted by authors JMM, RdN, 
NE and HE (see Supplementary Materials for interview schedules). The 
focus group with pwMS was co-facilitated by our PPI partner CB, to 
enhance data richness [25]. Interviews were audio-recorded and tran-
scribed verbatim. 
Participants were shown several resources to illustrate how the 
pathway might work and were asked to provide feedback. These 
included brief video demonstrations of digital cognitive screening tests 
(Paced Auditory Serial Addition Task [PASAT] [26], Symbol Digit Mo-
dality Test [27], Stroop [28]); examples of face-to-face assessments 
(Word List Learning [29], Verbal Fluency Test [30,31], Trail Making 
Test [32]); and, a self-report questionnaire (Multiple Sclerosis Neuro-
psychological Questionnaire [33]). The initial logic model (Fig. 1) was 
also shared. 
2.3. Analysis 
Anonymised transcripts were analysed on NVivo 12 using the 
Framework approach [34]. The logic model informed a working 
analytical framework (see Fig. 1 and Supplementary Materials for cod-
ing scheme) and data were mapped onto this. Review of the mapped and 
organised data informed a revision of the logic model based on the 
findings below. 
Yardley’s evaluative characteristics for good qualitative research 
were applied [35]. Regular team discussions were also held to modify 
the coding scheme to better represent the data [36]. Summary data were 
presented to a PPI group to sense-check our interpretations. 
3. Results 
3.1. Study participants 
Forty-four participants were interviewed (25–75 min), and 5 pwMS 
participated in the focus group (125 min). Characteristics for non- 
clinician stakeholders are presented in Table 1. Participating clinicians 
included four neurologists, MS nurse specialists, OTs and neuropsy-
chologists each, three healthcare commissioners, and one neuro- 
Table 1 
Participant characteristics for non-clinician stakeholders.   
People with MS- 
Interviews  
(n = 15) 
People 
with MS-  
Focus 
group  
(n = 5) 
Family 
Members  
(n = 5) 
Charity 
Volunteer  
(n = 4) 
Age  
M(±)  48(9.5)  49.6(7.1)  54.2(19.9)  42.3(7.6) 
Gender 
Female  12(80%)  4(80%)  1(20%)  3(75%) 
Ethnicity 
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physiotherapist. Recruitment stopped when we fulfilled our purposive 
sampling criteria and established data from a range of different 
stakeholders. 
3.2. Overview 
There was consensus on the current situation - cognitive problems 
were reported as prevalent and disruptive, and stakeholders recognised 
the need to address these problems using a standardised pathway. Dis-
cussions therefore focused on how the pathway would work. 
Data were organised into overarching themes (pre-defined logic 
model configurations), themes (core patterns) and sub-themes (further 
depth). Key results are presented for each overarching theme (inputs, 
outputs, mechanisms, outcomes) and supporting data are displayed in 
Tables 2–5, with superscript numbers linking relevant quotes to the text. 
When multiple participant groups endorsed a sub-theme the term 
‘stakeholders’ is used, otherwise the relevant group of stakeholders is 
specified (e.g., pwMS). 
3.3. Inputs (Resources) 
Clinical Staff were recognised as an important resource. Stake-
holders pointed to ‘competition’ between symptoms during clinic appoint-
ments, with limited time to address multiple MS symptoms1. Clinicians 
commented on the need to monitor drug treatments during the 
appointment, which took precedence over dealing with cognitive 
problems2. Physical symptoms including spasticity, bladder and bowel 
issues were often prioritised over cognitive problems3. 
Pressured workloads were also raised, particularly those of MS 
nurses4. Stakeholders reflected that any new pathway would impact on 
staff time5 and that it is unclear who might have the capacity to deliver 
this6. 
People with MS thought they would need to expend mental and 
physical resources to engage in the pathway. Travelling to hospital re-
quires time, effort and planning7. Digital technologies are also needed to 
access cognitive screening8. Further time commitments may be necessary 
from those attending multiple rehabilitation sessions9. Clinic facilities, 
including technology to host the cognitive screening (e.g., computer 
tablet, WiFi access10), and a clinic room where screening and support 
sessions could be completed11, was also identified as a key resource. 
Clinicians and commissioners thought understanding existing costing 
and commissioning frameworks and having a strategy in place to show 
how the proposed pathway addresses these drivers12 would help ensure 
the pathway is adequately resourced. 
3.4. Outputs (Activities) 
Stakeholders agreed that training was important to ensure that staff 
feel supported and have the skills to deliver the pathway. Clinicians 
thought training should address screening (administering and under-
standing the cognitive tasks)1, triaging (interpretation), and managing 
cognitive problems (goal setting, rehabilitation philosophy)2. Clinicians 
Table 2 
Key Input (Resource) themes and sub-themes with supporting data.  
Theme Sub-theme 
(Context) 
Sample of coded text  
Clinical staff Clinic appointment 
Time allocated to cognitive symptoms during 
limited clinic appointment 
1. And in our symptom management clinics where they have half an hour appointments, in that 
appointment we will be looking at bladder, bowels, fatigue, mobility, spasticity – you name it, it’s 
addressed in that. And if you touch on cognition, but again we don’t have time to sit there and go through a 
proforma or anything like that or any kind of referral. MS Nurse MS07 
2. There’s these new medicine, I give you this medicine, has it got any side effects, let me tell you about the 
side effects and so on. So, the competition for time is, do I – at the moment because we didn’t have the 
evidence base for the effective rehabilitation, there seem to be some pressure and probably it will take 
second priority in people’s minds. Neurologist N01 
3. So I usually really just tell her conversation about medication and that’s all there’s, you know, we have a 
bit of a tete a tete about that!  [Laughs] And that’s all there’s time for! Charity Volunteer CV05 
Pressured Workloads 
Capacity of multidisciplinary team members 
4. Personally my experience of MS…yeah, I don’t know how they would have the bandwidth to do this, it 
would be great if they do, but you know. Charity Volunteer CV05 
5. I would just worry a little bit about timing, if you’re doing it with everybody, because if they’ve got the – 
they’re also very limited on time and they’ll also be doing other OT roles as well. Neuropsychologist PS05 
6. I think probably the Occupational Therapists are more used to delivering cognitive screening, giving 
advice on cognition and especially in the sense of how we’re using the, you know, mechanisms – so the 
strategy that you’re suggesting – incorporating with everyday life. 
…I have the impression that they have possibly a bit more time than the MS nurses. Neurologist N01 
People with MS Physical & Mental 
Requires concentration 
7. Because it’s hard work when you have to get to a hospital appointment, even for those of us that drive 
and don’t have too much physical problems at any one time. It is hard work. Focus Group Male M2 
Planning.  Focus Group Male M1 
Yeah.  To get to [hospital 1], plus the expense, it’s a big thing. Focus Group Female F1 
Physical 
Requires travel, time away from work, access 
to technology, mobility 
8. They may not have the money to buy the machinery, machines to access the link, they may not be IT 
literate and they may just be plain right poorly, you know, too poorly to do it. PwMS P02 
9. And also trying to get the timing right as well because obviously a lot of people with MS are working so 
doing – if it’s one off group it’s easier, but if it’s a group over a number of sessions, doing it during working 
hours is difficult for people to commit to. Neuropsychologist PS03 
Clinic facilities Technology 
Availability of Wi-Fi, tablet, etc. 
10. We have a Wi-Fi. We have also NHS Wi-Fi which is free. MS Nurse MS05 
Clinic rooms 
Availability and management 
11. There is general mismanagement of rooms in the hospital. So once the MS nurses, they always find this 
space, because they find that the empty room and let’s go there for the next half an hour. Neurologist N01 
Costing and 
commissioning 
Commissioning frameworks  
Understanding, awareness and a strategy to 
address 
12. So what you’d need to do is cost out this programme in each of those areas, work out what their 
commissioning structures are for each of those areas and be very clear about what the key metrics are in 
terms of patient outcomes, experience, safety, funding. Commissioner CM03 
Note: Alpha-numerical codes represent participant ID numbers. 
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Table 3 
Key Output (Activity) themes and sub-themes with supporting data.  
Theme Sub-theme 
(Context) 
Sample of coded text 
Training packages Screening & Triaging 
How to support pwMS to complete 
screening and interpret the results 
1. I’m not sure our OTs, even our specialist rehab OTs would have used the digit symbol and some of these, 
so it’s kind of, you know, are introducing something new to people that then will need to interpret that, 
but I don’t think with training, I think that’s feasible isn’t it. Neuropsychologist PS05 
Cognitive management programme 
How to deliver and set goals 
2. Not all nurses have been through rehabilitation unit or rehabilitation training to kind of be aware of the 
notion of goalsetting and monitoring and motivational – you know. Neurologist N03 
Supervision 
Ongoing monitoring and support 
3. So if this is just an MS nurse working on their own then they might find it harder to make some of those 
decisions unless they’ve had some solid training and some supervision, ongoing supervision just to, you 
know, flush it out a bit. Neuropsychologist PS05 
4. I think it does definitely need to have a review and monitoring built into that. Neuropsychologist PS03 
Screening tool Administration 
How to enable completion of screening 
ahead of routine appointment 
5. That would be an ideal, digitalising the assessment pre-appointment. That would be wonderful…so 
when they come into clinic we have got everything there. MS Nurse MS05 
6. Interviewer 
So you wouldn’t have any problems filling that in and accessing the link. 
Carer C20 
No, no, not at all, I’d be alright. 
7. Which is obviously brilliant because the whole thing about a paper link is that someone then has to type 
it in. And as much as possible, isn’t it, you want someone to have the link on their device so they just have 
to click on it. Neurologist N03 
Cognitive measures 
Include short, sharp assessments that avoid 
mathematics 
8. Interviewer 
Did those tests seem relevant? 
PwMS P20 
Yeah, very much so, yeah.  Especially the one with the colours and the - 
Interviewer 
The Stroop test. 
PwMS P20 
Yeah, you know, it’s quite profound how your brain works because, you know, somebody without MS you 
still kind of have to really think one thing but you’re having to override it.  I think that’s a really good test 
9. Because I’ve got to think of too many numbers so I can’t focus on the number that I need to focus on 
because I’ve just done the total. So I will have forgotten that number.  I just couldn’t do that. Focus Group 
Female F1 
10. Your balances a bit, isn’t it, it’s finding something which is quick but MS nurses will be able to do with 
everybody quickly as part of their clinical interview while still being meaningful enough. 
Neuropsychologist PS03 
Screening results Transfer 
Electronic transfer to clinical team 
11. So probably for us it would be emailing to the MS coordinator, who would upload it onto the patient’s 
EPR so that it was there as an electronic document and then it would remain so, as opposed to lost in 
someone’s email and never available again. Neurologist N03 
Feedback report 
What should this include 
12. I think if we could categorise them really in a binary way or in these three categories, I think that 
would be excellent. That’s very practical and I think we all know pretty well who we’re thinking of when 
we’re thinking of these categories. Neurologist N02 
13. I mean, it might be useful to know in roughly what sort of domain we’re talking about the deficit as 
being, you know, so whether it’s a memory problem or whether it’s – I don’t know – been a processing 
problem or maybe something roughly categorising it a little bit further rather than just severity. 
Neurologist N04 
Communication 
How to communicate screening results to 
pwMS 
14. I think face to face is probably better than an email. Carer C20 
15. Well it depends what the result is. If it’s very severe, you’re going to need a consultant I think. Focus 
Group Male M2 
Triage Concurrent symptoms 
Interpret cognitive performance 
considering concurrent symptoms 
16. You will need somebody who’s quite skilled at interpreting the different components you’ve 
discussed, so the mood and the cognitive, to think about how best to manage their difficulties. 
Neuropsychologist PS03 
Perspective of person with MS 
Allow pwMS to indicate how they are 
feeling 
17. Everything’s all right, or you might be having a bad day but you picked up this. How do you feel about 
how this goes for you every day? Is this actually a problem or was it just, you know, that answer on the 
test? PwMS P27 
Functional impact 
How do cognitive problems affect pwMS 
18. I think as long as it’s then not prescriptive and it’s not taken at that value of it being the person in front 
of them is sitting there saying ‘I’m struggling at work’ and we turn round and go ‘but the screens don’t 
show us anything’ and then that’s taken as part of I suppose a triangulated discussion which you’d hope 




What should the programme cover  
19. And it could also provide a bit of information, you mentioned fatigue earlier and that having an impact 
sometimes. Charity Volunteer CV01 
20. Skills, different techniques, to help us and then you perhaps try and test it. Focus Group Male M2 
21. The way that people are making decisions, and in the way that they’re managing their condition or not 
managing their condition effectively. Occupational Therapist OT02 
22. If it’s abstract it’s very difficult for them to take, say reading something, or being given a handout to 
applying it. Neuropsychologist PS03 
Note: Alpha-numerical codes represent participant ID numbers. 
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raised supervision and ongoing monitoring3, recognising that post- 
training support4 would be beneficial. 
The online screening tool was a key focus for discussion (see Sup-
plementary Materials – Coding Scheme). Stakeholders felt that screening 
should be administered ahead of a clinic appointment, with the results 
enabling discussion during the appointment5. Most pwMS felt able to 
access the screening tool online at home6 and advocated sending a 
weblink to access the tool on a digital device7. 
PwMS understood the relevance of the cognitive measures presented 
to them and thought these were appropriately challenging8. However, 
some found the mental arithmetic task (PASAT) unpleasant9. Everyone 
agreed that cognitive screening should be brief. Clinicians acknowl-
edged the need to balance the sensitivity and brevity of screening 
tasks10. 
Clinicians thought that screening results should be digitised within 
patients’ medical records11. They felt that the feedback report should 
include cut-offs to help identify individuals who may require support12 
and enable discussions around the type and severity of the cognitive 
problem13. Most stakeholders thought the results should be communi-
cated face-to-face, at a routine clinical appointment, rather than over the 
telephone or via letter/email14. Communications should be initiated by 
a neurologist where problems are severe15. 
Stakeholders recognised the complexity of triage decisions and re-
ferrals. Where present, concurrent symptoms such as low mood and fa-
tigue needed to be interpreted in relation to cognitive problems16. 
Stakeholders also highlighted the importance of the perspective of pwMS. 
Triaging should consider how the person was feeling during cognitive 
screening and any extenuating circumstances (e.g., relapse, technology 
problems17). Stakeholders thought that pwMS should engage in these 
discussions to reflect upon the functional impact of cognitive problems18. 
Data relating to the cognitive rehabilitation/management pro-
gramme reiterated that concurrent symptoms need to be addressed by 
the pathway, through the provision of relevant information19. Stake-
holders felt the content should include compensatory strategies that can 
be implemented at home20 and gave examples of strategies they thought 
might work well (e.g., digital technologies21) or be less effective (e.g., 
abstract visualisation22). 
3.5. Mechanisms 
The complexity of cognitive problems was raised as an important 
mediator. Stakeholders highlighted the interdependence of symptoms and 
recognised that stress and fatigue can exacerbate cognitive problems1. 
Similarly, cognitively demanding activities left pwMS feeling fatigued 
Table 4 
Key Mechanism themes and sub-themes with supporting data.  
Theme Sub-theme 
(Context) 
Sample of coded text 
Complexity of cognitive 
problems 
Interdependence of symptoms 
e.g., cognition mood, fatigue 
1. Her cognitive issues come when she’s under stress, so she breaks down into this almost jelly like 
state. Carer C20 
2. There’s lots of tabs open in my head, that’s the only analogy I can put it down to and that creates the 
stress and then it’s almost like I can’t think straight and my head is like just all over the place and then 
that completely fatigues me. PwMS P20 
Nature of cognitive problems 
Brain-based or secondary reaction 
3. There’s also lots of questions about whether it’s associated with their mood or whether it’s to do with 
their MS or some other issues too, so those questions often come up quite a lot. Neuropsychologist PS03 
4. Sometimes I think we tend to think about real and not real cognitive problems and give the 
impression that we think the real ones are the ones related to scanning and your depressed, your tired, 
your sleepy patients do have cognitive problems, it’s just the means to address them are likely to be 
different. Neurologist N03 
Acknowledge individual differences 
Personal circumstances 
5. I guess that’s my question, like, how do I know I’ve got cognitive problems over and above the 
average 40 something year old. Charity Volunteer CV05 
6. We do have people who there can be a temptation sometimes to overegg your cognitive problems. 
Neurologist N03 
Engaging people with 
MS 
Rationale clearly explained 
Describe pathway and what it involves 
7. Someone might look at that and think “I don’t see why I’m doing this. I don’t understand why I’m 
being asked to do this. This has no bearing on my life. I’d never do a test like this in my real life”. PwMS 
P27 
8. I think that, no, it’s just explaining about the benefits they can get from it and that sort of thing. Carer 
C20 
Instructions 
Clear, concise instructions 
9. Yeah, I think definitely simplicity is definitely, yeah, the way to do it, yeah. PwMS P02 
Timing 
Align screening with an upcoming 
appointment and avoid point of diagnosis 
10. If it’s that sort of level and it can get fed back fairly quickly at the next appointment, that – ‘cause 
you don’t want to be sitting worrying about it, you want to have something pretty quick. PwMS P27 
11. I think maybe if they’d told me in advance ‘we’re going to do a very basic, you know, cognitive test, 
it’s nothing to worry about, we’ll explain it, please don’t do any preparation, but just be relaxed about 
it’, I think that probably would have helped. Charity Volunteer CV05 
12. I think if I’d known about in advance, you know, I might have then overthought it, to be honest. 
Charity Volunteer CV05 
13. I think as people have said before, it’s like what stage you’re at and whether you want to look or 
whether you need to look. Focus Group Female F1 
14. I had no idea about the cognitive things until later on and that was a nasty shock. Yeah, I think being 
more upfront about things might be, would be useful. PwMS P27 
Home-based completion 
Remote screening allows flexibility and 
convenience 
15. I think so. I think a lot of people would be happier doing that at home. It’s more of a – yeah – it’s that 
less stressful situation, you know. Carer C20 
16. Doing it during working hours is difficult for people to commit to. Neuropsychologist PS03 
17. I can imagine there’s people who are really not au fait with computers, with it all becoming paper 
free and that stuff. PwMS P28 
18. I think discussion in person one to one, whether that be a consultant or MS nurse, is probably the 
way to start it off. PwMS P27 
(continued on next page) 
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and drained2. Stakeholders thought the pathway should recognise that 
some cognitive problems will stem from brain damage driven by MS, 
whilst others are a secondary reaction to living with MS3. Clinicians 
thought this was an important distinction to observe4. Stakeholders 
suggested the pathway should also acknowledge that individual differ-
ences could influence cognitive performance and the effectiveness of 
support programs, and the perspective of related informants need to be 
addressed5,6. 
Engaging pwMS addresses their reactions towards the pathway. 
Stakeholders felt pwMS should be informed about the rationale for the 
pathway. Explanations should reassure them that the pathway is mean-
ingful7 and clarify how it will inform their clinical care8. Stakeholders 
thought information should be clearly communicated avoiding medical 
jargon9. 
The timing of the pathway is an important mediator for pwMS. 
Stakeholders thought invitations to complete the screening should be 
aligned with a routine appointment where the results can be commu-
nicated without delays10. Most pwMS supported the idea of being told 
about the screening tool in advance of their appointment11 but 
acknowledged some might worry about this12. Some thought receiving 
information about the pathway might overwhelm newly diagnosed 
patients13, while others felt cognitive problems should form part of these 
early conversations14. 
Stakeholders indicated that home-based approaches (e.g., online 
screening, telephone follow-ups for the cognitive management pro-
gramme) would be convenient and less stressful for most pwMS15, 
particularly those in employment who cannot attend multiple appoint-
ments16. However, home-based approaches were not perceived as 
feasible for all17; stakeholders thought access to additional support 
(telephone or face-to-face in-clinic) would promote engagement18. 
Engaging clinical staff encompassed clinicians’ reflections on which 
team members they thought responsible for addressing cognitive prob-
lems. Some thought MS nurses and neurologists would not consider 
cognitive problems as part of their role19 or see this as beyond their 
expertise20. Other clinicians perceived cognitive problems as a shared 
responsibility and thought the pathway should advocate a team-based 
approach21,22. Clinicians acknowledged that staff have different prior-
ities and thought willingness to prioritise cognitive problems would promote 
acceptance of the pathway23. 
Stakeholders thought the pathway should foster shared values, 
including a person-centred approach where care is tailored to the needs of 
the individual24. The pathway should recognise the differing impact that 
Table 4 (continued ) 
Theme Sub-theme 
(Context) 
Sample of coded text 
Engaging clinical staff Perceived responsibility 
As an individual and within a clinical team 
19. I am trained to give medicines. So, why to see patients and make sure that they have all medicine’s 
correctly. So there will be some doctors that will not be keen doing this 2 min in a consultation. 
Neurologist N01 
20. I think that it’s not part of their role, they wouldn’t see it as part of their role and it’s slightly out of 
their competency I suppose…it’s not traditionally seen as a nurse thing, I don’t think, it’s more a 
psychology, an occupational therapist, you know, an OT thing, yeah. Neuropsychologist PS01 
21. I actually do think it needs to be you know, every symptom and management kind of needs to be 
sort of kind of responsibility for everybody. Occupational Therapist OT04 
22. So it’s really useful to have that team approach to cognitive difficulties. Neuropsychologist PS03 
Willingness and motivation 
To adopt an alternative approach 
23. Yes, we absolutely value the importance of cognition. And that would be no problem at all from our 
perspective, in terms of making that a key priority. Occupational Therapist OT02 




24. Not the same thing works for everybody, so I think a kind of basic starting point and then 
personalise it after that would be a good idea. Charity Volunteer CV01 
25. How much it’s impacting somebody’s life, so you can have, you know, quite mild difficulties but 
that really impact on somebody’s life, or you can have moderate difficulties which aren’t really 
impacting. Neuropsychologist PS03 
26. I suppose it’s meaningful to that person, rather than it just being a lot of suggestions thrown at 
them, that it is meaningful to that person. Neuropsychologist PS05 
Holistic 
Care for the person as a whole 
27. We want to ensure there’s parity, that these people get parity of esteem, that they’re whole system. 
Commissioner CM02 
28. So there’s always been very holistic, very focused on physical rehab as well as psychological and 
cognitive. Neuropsychologist PS04 
Proactive 
Initiate and act  
29. I feel like that could have quite a protective element to it …and it helps them, it empowers them to 
speak about their difficulties as well with language that they understand. Neuropsychologist PS05 
30. It’s to help and it’ll help yourself and it’ll help others and just go that way. Carer C20 
31. So if somebody is really, really depressed, again through struggles with their memory and they will 
probably struggle with initiation as well because they’ll be so low, so actually probably implementing 
some memory strategies might be difficult for them. Neuropsychologist PS03 
Positivity 
Encourage a positive attitude 
32. Somebody who’s like inspiring, positive, you know, that’s what I would love. Focus Group Female 
F1 
33. It’s about retaining a positive mind and a positive mindset. PwMS P20 
Manage Expectations 
Coping with cognitive problems - not 
retraining cognitive skills 
34. It’s about this is a way of managing and understanding, not a way of getting rid of difficulties. 
Neuropsychologist PS05 
35. But I think it’s very important in terms of the language we’re giving MS nurses and other 
professionals who are then going to be feeding this back and doing cognitive rehabilitation is the idea 
that coming on these four sessions, it’s not going to make this any better, but it may help you to live 
with it better. Neuropsychologist PS05 
36. I want to recover, yes, I do want to compensate and find other strategies in the meantime, but I still 
want to feel that it’s something I can regain and rebuild. Charity Volunteer CV05 
37. And there are really difficult conversations to have with lots of people we work with and you’re 
going ‘actually there’s no evidence for that’. Neuropsychologist PS05 
Note: Alpha-numerical codes represent participant ID numbers. 
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cognitive problems have25 and ensure support strategies are meaningful 
to the individual26. Some stakeholders recommended adopting a holistic 
approach to care27, incorporating physical and psychological 
wellbeing28. 
The pathway should empower pwMS to be proactive and to take ac-
tions which target milder cognitive problems29,30. However, stake-
holders also acknowledged some pwMS will not be motivated to engage 
with this because of fatigue and cognitive problems31. 
PwMS thought the pathway should promote a positive outlook and 
inspire them32,33. However, clinicians recognised the need to manage 
expectations, e.g., manage problems rather than restore abilities34,35. 
These discussions can be frustrating for pwMS who want their cognitive 
abilities restored36. Stakeholders thought appropriate information 
might temper unrealistic expecations37. 
3.6. Outcomes 
We elicited ‘short-term’ outcomes of the pathway from the data, 
including improved access to standardised clinical care for cognitive 
problems. Clinicians spoke about the lack of formalised guidelines for MS 
services1 and thought the pathway would address this2. Clinicians and 
commissioners felt the pathway would facilitate conversations about 
cognitive problems by providing information about patients’ symp-
toms3,4. These conversations were also perceived positively by pwMS5, 
who valued the opportunity to discuss cognitive problems6 and have 
their concerns validated7,8. 
Some stakeholders acknowledged that anticipating the screening 
results could worry pwMS9. Moreover, being reminded of symptoms and 
noticing cognitive decline might be upsetting10,11. Consequently, some 
pwMS may disengage with the pathway12. 
‘Longer-term’, stakeholders thought being able to understand and 
manage cognitive problems would improve quality of life amongst 
pwMS13,14. Earlier detection and management of problems might even 
prevent deterioration15 and prolong independence16. Stakeholders indi-
cated that early detection and management could promote efficient use of 
NHS resources17,18. Home-based cognitive screening was also considered 
Table 5 
Key Outcome themes and sub-themes with supporting data.  




Formal guidelines and referral pathways 
1. Cognitive problems in people with MS they aren’t routinely identified within normal practice, so no 
standardised way. Neuropsychologist PS03 
2. I think if there’s a tool there to use, I think it would facilitate, I can see it leading to more! 
Neuropsychologist PS05 
Opportunity to discuss cognitive problems 
Confidence and competency to discuss 
3. The patient would complete this and it would give more information to whoever is seeing them at their next 
appointment to further their conversation. Commissioner CM03 
4. I think if it creates a conversation, I think anything is helpful and if it prompts the conversation in the 
direction of triangulating that with the patient experience and any observations that the team or families can 
offer, then it’s doing the right thing. Neuropsychologist PS05 
Short-term: 
People with MS 
Opportunity to discuss cognitive problems 
Better able to understand and manage their 
condition 
6. It helps them, it empowers them to speak about their difficulties as well with language that they 
understand. Neuropsychologist PS05 
7. It feels so subtle that I think when those people mention that, it can be so easily dismissed as it’s not 
impacting that much, but actually it can have a huge impact. Neuropsychologist PS05 
8. I think it is about facing it on, it’s not about keeping it down there, you have to face that you have had some 
changes and run with it, rather than hiding it, so I think questionnaires are good. PwMS P20 
Remind person of their symptoms 
Being reminded of symptoms could be 
upsetting 
9. In terms of doing a test on your own at home feeling like you’ve really struggled with it and then not having 
anyone to talk to about that until you’re at your appointment, which is then filled with lots of other things, 
could feel quite isolating. Neuropsychologist PS05 
10. It depends what sort of relationship they’ve got and obviously their disability as well, you know, how it’s 
impacted so it can be quite emotional for some people I suppose. PwMS P20 
11. And it’s basically whether it is actually upsetting to some people to realise just where you were to where 
you are now, and that really upset me, from that point of view. PwMS P28 
12. There are some people who, for a number of reasons, do not want things measured or recorded. 
Neurologist N03 
Longer-term Quality of life 
Improved confidence and productivity 
13. I suspect that if people felt their cognition was better, they would have more confidence and more 
willingness to go out and do things and try things. PwMS P27 
14. And the idea that if you invest in a strategy to make life a bit easier then you probably may not get fatigued 
as quickly. Neuropsychologist PS05 
Prevention 
Earlier detection and intervention to reduce 
impact of cognitive problems 
15. It’s like why wait for the problem, just, you know, if people knew about that then they could get, they 
could work on it and get better and slow down the progression of cognitive depletion. PwMS P20 
16. I I If they understand those changes earlier and they can learn the strategies then potentially that might 
protect employment. Neuropsychologist PS05 
Efficient use of resources 
Optimise NHS resources 
17. I mean, is this going to stop people ending up having unnecessary attendances or admissions into hospital, 
or is it going to just keep people more able to live at home for longer on their own or whatever it is. 
Commissioner CM03 
18. Yeah – and also the not having to – if they’re not going to some services then they don’t have to travel and 
the cost and impact that it has on that. Commissioner CM03 
19. Proposal of having patient to carry out assessment online at home, and is not coming to me, to clinician, I 
think is an excellent idea. MS Nurse MS05 
Potential increase in referrals to psychological 
services 
Pathway could overwhelm already pressured 
services 
20. This new activity that you are going to be potentially offering here is going to be – this in itself is going to 
cause more outpatient appointments, isn’t it, it’s going to cause more – it’s going to encourage more 
appointments, or is this in Primary Care? 
- so there’d be more activity in Secondary Care on the back of the fact that people would be called in for 
cognitive appointments. Commissioner CM03 
21. But for us actually we have a massive delay to CBT and talking therapies. Neurologist N03 
Note: Alpha-numerical codes represent participant ID numbers. 
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efficient, reducing the time required with a clinician19. Stakeholders 
reflected on a potential increase in referrals to psychological services20, 
which could overwhelm already pressured services21. 
4. Discussion 
Stakeholder feedback confirmed that staff time, training packages, 
brief online screening tasks, and person-centred support for cognitive 
problems are important elements in the pathway. Improved access to 
care and clearer referral pathways for cognitive problems were still 
thought of as possible outcomes (as in Fig. 1). However, our data also 
offers new insights that challenge the initial logic model and enabled us 
to consider implementation more directly. Fig. 2 reflects a revised logic 
model that could inform subsequent service development. 
‘Resources’ replace ‘Inputs’ to reflect the importance of stakeholder 
investment. Our revised model recognises the need for staff to allocate 
time for the pathway during already stretched clinic appointments and 
pressured workloads. Stakeholders felt the capacity of MS nurses was 
particularly limited and this led us to reconsider which team members 
are best placed to support a new pathway. Other staff (e.g., psycholo-
gists, OTs) can be involved with appropriate training. Kalb et al. [6] 
acknowledge insufficient resources and highlight the lack of adequately 
trained clinicians as barriers for addressing cognitive problems. Training 
was therefore retained within the revised model with cognitive 
screening, triaging, management, and supervision packages now speci-
fied to reflect our new insights and explain how services can equip 
multi-disciplinary team members to deliver the pathway. Improved 
awareness of the importance of addressing cognitive problems within 
healthcare drivers/ recommendations and accepting shared re-
sponsibility for cognitive problems as part of comprehensive care pro-
vision amongst the wider neurology community will also help engage 
clinical staff with the pathway. 
The ‘Activities’ component (previously labelled ‘Outputs’) supports 
recommendations that computerised testing is a means to implement 
cognitive screening in routine care (13). Electronic data gathered in this 
way may be integrated within patient records to promote routine 
monitoring [37]. Our study builds on this by demonstrating how and 
when cognitive screening could be undertaken (i.e., remotely prior to an 
upcoming clinic appointment with the option to access additional sup-
port). This may facilitate clinical implementation and sustainability. 
Our revised logic model reflects the nature of cognitive problems and 
individual circumstances as important mediating factors. Medications, 
age, selection/scoring of cognitive assessments, comorbid health con-
ditions and concurrent symptoms can affect cognitive problems [6]; 
assessing these factors is therefore recommended for optimal cognitive 
management [38]. Interpreting and contextualising results (because of 
this) might be challenging and staff training is needed to facilitate 
consultations and aid triage decisions. Psychoeducation focussing on 
concurrent symptoms should also be provided to pwMS. 
Our findings provided insights into the content of the cognitive 
rehabilitation programme. This should be person-centred, encompass-
ing psychoeducation and behavioural strategies to help pwMS cope with 
cognitive problems - not retrain cognitive skills. The rehabilitation 
programme was therefore relabelled as ‘cognitive management’ to bet-
ter reflect the content and ethos of the programme. This is consistent 
with previous research which has demonstrated improved mood and 
self-reported memory problems, but no restorative cognitive effect 
following rehabilitation in MS [39]. 
Stakeholders thought a combination of face-to-face and telephone- 
based programme sessions would be preferable; Goverover et al. [12] 
have shown increased adoption associated with such combined ap-
proaches, which has since been accelerated and optimised by the 
COVID-19 pandemic [40]. Online cognitive screening and 
telephone-based support will be important in engaging stakeholders and 
in utilising clinic resources efficiently. 
Stakeholders thought the pathway would help facilitate 
conversations about cognitive problems but recognised that imple-
mentation could increase referrals to psychological services. Our revised 
logic model now acknowledges this possibility as a ‘longer-term’ 
outcome. 
Stakeholders also felt the impact of cognitive screening on the 
wellbeing of pwMS should be considered. Most pwMS valued the op-
portunity to discuss cognitive problems but acknowledged that some 
could feel anxious (about screening) and depressed (if the results indi-
cated a problem). These potential outcomes will be monitored as part of 
NEuRoMS. Ultimately, stakeholders felt referral pathways could help 
optimise resources (staff can treat those most likely to benefit from their 
help), prevent mild cognitive problems becoming more severe, and 
prolong functional independence - all key priorities in managing long- 
term neurological conditions [41]. 
In line with MRC recommendations [11], we took a theory-based 
approach to intervention development to model the causal processes 
of the pathway. Conducting new primary research with a varied sample 
of stakeholders offers an in-depth and diverse understanding into how 
the pathway might work, recognising important mediating factors for 
implementation. The resulting pathway is now more relevant and 
theoretically sound, and therefore more likely to be implemented by 
stakeholders [23]. 
Nonetheless, our results are based on data gained from a research 
sample. Other stakeholders might offer further nuance to our under-
standing - for instance, we did not include IT specialists who would be 
responsible for data linkage from the screening results to the patient 
notes and ultimately integrating the pathway within existing IT systems. 
This, and insight from subsequent pathway piloting, will contribute to 
the iterative development of the logic model. 
Our model is thus a blueprint that healthcare professionals could adapt 
to suit local circumstances, with local pathways being designed in the 
nexus of our logic model and local needs/resources. We view the training 
packages, screening tool, triaging and cognitive management programme 
(resulting in an integrated care pathway) as core elements to be retained 
across healthcare systems/pathways. However, availability and commis-
sioning of resources will differ across healthcare models. For those low- 
income and middle-income countries where patients do not routinely 
receive disease modifying therapies, this might be prioritised in terms of 
funding [42]. Access to technology (e.g., tablet and Wi-Fi access for 
screening in-clinic) may also be limited here. Transferring the screening 
results to the clinical team will also require contextual strategies to inte-
grate the results within existing record keeping systems (e.g., digital soft-
ware, paper-based files) and ensure accessibility. Engagement mechanisms 
of timing screening to coincide with an upcoming appointment and 
providing the option of in-clinic support will also vary, with healthcare 
systems showing considerable variation in the frequency of consultations 
(e.g., quarterly versus annually [43]), which will influence the timing of 
appointments. Our model offers MS clinics the flexibility to work within 
the constraints of their systems and integrate existing successful practices. 
5. Conclusions 
Existing MS clinical pathways have not been co-constructed with 
stakeholders and are not based on robust evidence [19,44]. We have 
developed a multi-stakeholder, co-constructed, clinical pathway for 
routine screening and management of cognitive problems in MS. Our 
stakeholders felt that introducing brief online screening tasks (with 
options to complete in-clinic or at home) and support for self-managing 
cognitive problems (including mild problems), would improve quality of 
life for pwMS and streamline NHS resources through earlier detection 
and intervention. Clinical staff will need to invest their time and require 
training, while pwMS should be supported to actively participate in the 
pathway. As part of the NEuRoMS programme, the clinical and 
cost-effectiveness of the pathway will be evaluated in clinical trials 
encompassing intervention fidelity, health economics, and process 
evaluations. 
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Fig. 2. Revised Logic Model Based on Stakeholder Input.  
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Torrentà, L, 2019. Cognitive Dysfunctions and Assessments in Multiple Sclerosis. 
Front. Neurol. 10. 
[39] Lincoln, N.B., Bradshaw, L.E., Constantinescu, C.S., Day, F., Drummond, A.E., 
Fitzsimmons, D., et al., 2019. Cognitive rehabilitation for attention and memory in 
people with multiple sclerosis: a randomized controlled trial (CRAMMS). Clin. 
Rehabil. 0269215519890378.  
[40] Moccia, M., Lanzillo, R., Morra, V.B., Bonavita, S., Tedeschi, G., Leocani, L., et al., 
2020. Assessing disability and relapses in multiple sclerosis on tele-neurology. 
Neurol. Sci. 1. 
[41] The Neurological Alliance. The long term plan for the NHS: getting it right for 
neurology patients [Report]. 2018 [cited 2020 28 April]. 27]. Available from: htt 
ps://www.neural.org.uk/assets/pdfs/2018-08-long-term-plan-for-nhs.pdf. 
[42] Cerqueira, J.J., Compston, D.A.S., Geraldes, R., Rosa, M.M., Schmierer, K., 
Thompson, A., et al., 2018. Time matters in multiple sclerosis: can early treatment 
L. Smith et al.                                                                                                                                                                                                                                    
Multiple Sclerosis and Related Disorders 49 (2021) 102563
12
and long-term follow-up ensure everyone benefits from the latest advances in 
multiple sclerosis? J. Neurol. Neurosurg. Psychiatry 89 (8), 844–850. 
[43] Kobelt, G., Thompson, A., Berg, J., Gannedahl, M., Eriksson, J., the MSCOI Study 
Group, 2017. New insights into the burden and costs of multiple sclerosis in 
Europe. Mult. Scler. J. 23 (8), 1123–1136. 
[44] Rieckmann, P., Centonze, D., Elovaara, I., Giovannoni, G., Havrdová, E., 
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